<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How does INDP's Q3 2024 profit compare to peers?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        5/9/2025 02:38am
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Indaptus Therapeutics (INDP) experienced a net loss of $3.07 million in Q3 2024, while its peers, Novo (NOV) and Celsius Holdings (CELG), reported net incomes of $130 million and $6.36 million, respectively. This indicates that INDP's financial performance in Q3 2024 was significantly worse than that of its peers.


|code|Ticker|Name|Date|Net Income|market_code|
|---|---|---|---|---|---|
|INDP|INDP.O|Indaptus|2024 Q1|-3806677|186|
|INDP|INDP.O|Indaptus|2024 Q2|-4015267|186|
|INDP|INDP.O|Indaptus|2024 Q3|-3069036|186|

</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw,ax,ay){return {layout:"default",data:[{noData:c,currentQuestion:g,textDescription:W,comeFrom:"AInvestShareLink",events:[],answerSource:o}],fetch:{},error:p,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:q,agent_id:a,output_media_info:[],task_id:a,language:a,source:o,cache_builder:a,reply_action:"Answer",execute_mode:G,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How does INDP's Q3 2024 profit compare to peers?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How does INDP's Q3 2024 profit compare to peers?\",\"user_id\":\"dp95637481\",\"user_name\":\"\",\"trace_id\":\"4de14761-2ad6-4dd1-976b-b12fed433b27\",\"session_id\":\"4de14761-2ad6-4dd1-976b-b12fed433b27\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:k,text:"3 results found:\n|stock code|stock name|Last Price|Last Change|Net Income[20240930]|Report End Date|\n|---|---|---|---|---|---|\n|NOV|NOV|$12.37|4.52%|$130 million|20240930|\n|CELH|Celsius Holdings|$35.52|-0.77%|$6.36 million|20240930|\n|INDP|Indaptus|$0.44|1.81%|-$3.07 million|20240930|\n",query_data:{number:X,title:H,query_type:k,condition:a,model_sql:Y,data_ext_params:{merge_repeat:c,expand_index:b,data_add:q,add_index:e}}}],answer_chain_name:Z,agent_mode:_,native_answer:a,come_from:a,text_answer:W,trace_id:i,cost:26215,event_names:a,question:g,fallback_type:$,input_type:aa,fall_back_reason:{fall_back_type:$,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:i,first_return_cost:2641,cache_type:"no_cache",question_id:i,transfer_question:g,signal_type:"ON_COMPLETE",start_time:I,remote_svc:o,slots:[],answer_type:G,user_id:A,skill_name:J},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:i,session_id:i,user_id:A,question:g,source:o,raw_question:g,version:"3.4.1",action_name:J,nlu:{entity:[{type:B,value:C,market:l}]},output_time:I,deep_research:c,deep_thinking:c,agent_mode:_},extra:{}},{answer_path:r,section:{id:s,info_texts:["Thinking"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:r,section:{id:s,info_texts:["Searching Web: Indaptus Technology Peers"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:ab},logs:[],extra:{action:"Searching Web",action_input:"Indaptus Technology Peers",thought:"The user wants to compare INDP's Q3 2024 earnings with its peers. I should focus on identifying key peers and gathering relevant earnings data. I will use Search to identify INDP's peers. Then, I will use FinQuery for the earnings data of INDP and its identified peers."}},{answer_path:d,section:{id:m,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:r,section:{id:s,info_texts:["Querying Stock: INDP, BEIG, CELG, NOVN Net Income in Q3 2024"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:ab},logs:[],extra:{action:"Querying Stock",action_input:H,thought:"I have identified Indaptus Therapeutics' peers, including Beigene, Celgene, and Novartis. Since comparison is needed, Now I will use FinQuery to obtain the Q3 2024 earnings data for INDP and these peers together."}},{answer_path:d,section:{id:m,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:r,section:{id:s,info_texts:["Generating Answer"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:h,info_texts:[],show_type:u,voice_txt:"Ind",text_answer:ac,rich_text:ac,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:u,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:H,query_type:k,trace_data:a,index:X,model_sql:Y,data_ext_params:{merge_repeat:c,expand_index:b,data_add:q,add_index:e},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:h,info_texts:[],show_type:u,voice_txt:". This",text_answer:ad,rich_text:ad,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:D,market_id:l,name:v,domain:B},pos:e,section_id:h,txt:v,jump_type:K},{stock_info:{code:L,market_id:"169",name:L,domain:B},pos:104,section_id:h,txt:L,jump_type:K},{stock_info:{code:"CELH",market_id:l,name:ae,domain:B},pos:113,section_id:h,txt:ae,jump_type:K}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:h,info_texts:[],show_type:u,voice_txt:"\n",text_answer:af,rich_text:af,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:h,info_texts:[],show_type:ag,choice:[],result_page:{components:[{uuid:"cdb680792d2bf16e",config:{score:16,show_type:ah,scoreRuleNames:"value_unit;data_size;",showDataZoom:b,show_type_id:101,title:"柱状图",render:{x:w,y:[E]},title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:ai,h2:a},show_type:M}},data:{chunks_info:"[]",code_count:q,columns:[{index_name:N,key:N,label:"hq_code",source:O,type:f},{domain:P,feKey:Q,index_name:Q,key:Q,label:N,origin_index:"stock code",source:O,type:f,unit:a},{domain:P,feKey:R,index_name:R,key:R,label:"name",origin_index:"stock name",source:O,type:f,unit:a},{feKey:w,index_name:w,key:w,label:"date",origin_index:w,type:"DATE"},{domain:P,feKey:E,index_name:E,key:E,label:a,source:a,timestamp:a,type:"DOUBLE",unit:"USD"},{index_name:aj,key:aj,type:f}],condition:"[{\"sonSize\":2,\"opName\":\"and\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@stock code\",\"indexProperties\":[\"EQUAL CELG\\u003e-\\u003cNOVN\\u003e-\\u003cBEIG\\u003e-\\u003cINDP.O\"],\"indexPropertiesMap\":{\"EQUAL\":\"CELG\\u003e-\\u003cNOVN\\u003e-\\u003cBEIG\\u003e-\\u003cINDP.O\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Net Income\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20240930\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20240930\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0}]",dataSize:S,datas:[{"Net Income":-3806677,code:D,Ticker:C,market_code:l,Date:"2024 Q1",Name:v},{"Net Income":-4015267,code:D,Ticker:C,market_code:l,Date:"2024 Q2",Name:v},{"Net Income":-3069036,code:D,Ticker:C,market_code:l,Date:"2024 Q3",Name:v}],meta:{extra:{}},row_count:q,status_code:e,status_msg:"ok"},category:"generic",chart_type:"bar",show_type:ah,title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:ai,h2:a},show_type:M},support_refresh:b,data_config:{query:a,query_type:k,data_ext_params:{}}}],global:{query_type:k},page:{language:a,layout:{layout_data:"[{\"children\":[],\"showType\":\"bar3\",\"uuid\":\"cdb680792d2bf16e\"}]"},render_for:T},data_config:{query:a,query_type:k,data_ext_params:{}}},tag_info_list:[],is_last:c,uuid:"5d58b446-99bd-4709-9c41-d3a05a8f2307"},logs:[],extra:{}},{answer_path:d,section:{id:h,info_texts:[],show_type:u,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:r,section:{id:s,info_texts:["Completed"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:ag,choice:[{display_text:x,query_text:x,trace_info:{item_id:"dea22fe5f28cb5244da61295cfea9e2b",item_type:n,item_name:x,rec_info:ak}},{display_text:y,query_text:y,trace_info:{item_id:"b3068b77116134bae8deacb08acd0ad9",item_type:n,item_name:y,rec_info:al}},{display_text:z,query_text:z,trace_info:{item_id:"3a9d9d319b903fc7d99c4792990432a7",item_type:n,item_name:z,rec_info:am}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:M,data:{h1:a,h2:a},config:{display:c,txt_style:e,type:"1",display2:c,url:a}},request_config:[{source_type:S,related_name:an}],puuid:U,tag:a,category:"custom",uuid:ao}],global:{urp_static_data:[{name:an,value:{status_code:e,columns:[{type:f,index_name:ap,key:ap},{type:f,index_name:aq,key:aq},{type:f,index_name:ar,key:ar},{type:f,index_name:as,key:as},{type:f,index_name:at,key:at}],datas:[{send_text:x,item_type:n,rec_info:ak,display_text:x,rec_reason:a},{send_text:y,item_type:n,rec_info:al,display_text:y,rec_reason:a},{send_text:z,item_type:n,rec_info:am,display_text:z,rec_reason:a}],dataSize:S,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:au,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:F,"min-height":"100%",position:av,height:F},isMaterial:c,id:au,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:V,componentUuid:ao,script:[{name:aw,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:V,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:V},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:F,position:av,height:F},isMaterial:b,_id:19,id:aw,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:T,voice_txt:a,tracking_info:{},uuid:U},order:{is_auto:c,render_for:T,chart_type:"command",puuid:U}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:J,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:G,answer_chain_name:Z},is_deep_research:c,deep_thinking:c,create_time:1746729546394},is_last:b}],questionItem:{data:{qStr:g,encodeFlag:c,imageData:p,docsData:[],quoteData:p},tplType:"question"},events:ax,agentId:a,param:{entity_info:{},add_info:{ori_question:g},event_list:ax,client_ip:a,question:g,user_id:A,user_name:a,trace_id:i,session_id:i,source:o,input_type:aa}}],userId:A,userName:a,startTime:I,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:p,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:e,traceTableData:p,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-does-indps-q3-2024-profit-compare-to-peers-288778\u002F",config:{_app:{basePath:ay,assetsPath:ay,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer",0,"STR","How does INDP's Q3 2024 profit compare to peers?",2001,"4de14761-2ad6-4dd1-976b-b12fed433b27","signal","intusstock","186",999,"llm_generated","ths_ainvest_lite_web",null,1,"progress\u002Fsearching_for",1000,"searching_for","rich_text","Indaptus","Date","🎯 What is INDP's projected Q3 2024 earnings growth rate?","📈 How do analysts rate INDP's Q3 2024 earnings performance?","📊 Has INDP's Q3 2024 earnings exceeded market expectations?","dp95637481","stock","INDP.O","INDP","Net Income","auto","agent","INDP, BEIG, CELG, NOVN Net Income in Q3 2024",1746729520179,"review stocks","pos_fenshi","NOV","title1","code","fixed_index","abs_国际美股领域","Ticker","Name",3,"aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Indaptus Therapeutics (INDP) experienced a net loss of $3.07 million in Q3 2024, while its peers, Novo (NOV) and Celsius Holdings (CELG), reported net incomes of $130 million and $6.36 million, respectively. This indicates that INDP's financial performance in Q3 2024 was significantly worse than that of its peers.\n\n\n|code|Ticker|Name|Date|Net Income|market_code|\n|---|---|---|---|---|---|\n|INDP|INDP.O|Indaptus|2024 Q1|-3806677|186|\n|INDP|INDP.O|Indaptus|2024 Q2|-4015267|186|\n|INDP|INDP.O|Indaptus|2024 Q3|-3069036|186|\n\n",6,"select   stock_code,   net_income from   ustock_fin_data where   report_end_date = date('2024y3q')   and stock_code in ('INDP.O', 'BEIG.O', 'CELH.O', 'NOVN.O')","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite","thinking","Indaptus Therapeutics (INDP) experienced a net loss of $3.07 million in Q3 2024, while its peers, Novo (NOV) and Celsius Holdings (CELG), reported net incomes of $130 million and $6.36 million, respectively[^6]",". This indicates that INDP's financial performance in Q3 2024 was significantly worse than that of its peers.\n\n","Celsius Holdings","\n``` visual\n{\"uuid\":\"5d58b446-99bd-4709-9c41-d3a05a8f2307\"}\n```","result_page","bar3","INDP Net Income","market_code","2+679_496_21_554+0+0+4de14761-2ad6-4dd1-976b-b12fed433b27+dea22fe5f28cb5244da61295cfea9e2b+llm_generated+aimeTagAnalysis+0+0.01108817383646965+1","2+679_496_21_554+0+0+4de14761-2ad6-4dd1-976b-b12fed433b27+b3068b77116134bae8deacb08acd0ad9+llm_generated+aimeTagAnalysis+0+0.008213324472308159+2","2+679_496_21_554+0+0+4de14761-2ad6-4dd1-976b-b12fed433b27+3a9d9d319b903fc7d99c4792990432a7+llm_generated+aimeTagAnalysis+0+0.00683965627104044+3","recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>